Exercise and cancer: a position statement from the Spanish Society of Medical Oncology.

Introduction

Regular and adequate physical activity (PA) is associated with key benefits to human health, such as improvements in weight control, muscular and cardiorespiratory fitness, bone and functional health and a reduced risk of falls and several noncommunicable diseases, including diabetes, cardiovascular disease, depression and some cancers [ 1 ].

Due to improvements in the management of cancer, the number of cancer survivors and survival time are increasing. Consequently, interest in healthy behaviors, such as PA, and their potential impact on cancer- and non-cancer-related morbidity in these individuals has rapidly increased [ 2 ].

Commissioned by the Spanish Society of Medical Oncology (SEOM), in this review, we sought to distill the most recent evidence on this topic, focusing on the mechanisms that underpin the effects of PA on cancer, describing the role of PA in cancer prevention and prognosis, and providing practical recommendations to clinicians on managing PA counseling.

Biological mechanisms underpinning the potential anticancer effects of exercise

Of note, PA is any bodily movement produced by skeletal muscles that requires energy expenditure, whereas exercise is a subset of PA that is planned, structured and repetitive and that has a final or an intermediate objective of improving or maintaining physical fitness. The epidemiological evidence regarding the risk of some cancers mainly refers to regular PA (usually self-reported, i.e., through questionnaires). Thus, regular exercise or “exercise training” is a proxy, but not a perfect surrogate, for PA and is thought to induce more profound molecular adaptations than PA.

There is growing evidence from preclinical research that regular exercise can influence cancer development or the rate of tumor growth once malignancy has initiated. For instance, a recent meta-analysis of 28 preclinical studies in breast tumors ( n = 2085 animals) found large favorable effects for exercise training on proliferation and apoptosis [ 3 ]. Exercise is also emerging as a potential coadjuvant treatment; when combined with cyclophosphamide, exercise delays murine breast tumor growth versus chemotherapy alone [ 4 ], and similar findings have been reported for exercise combined with anthracyclines [ 5 – 7 ]. There is, however, heterogeneity among studies in the tumor models used, ranging from tumor transplant (where there is also substantial variability, e.g., syngeneic versus xenograft models) to carcinogen-induced or genetically engineered mouse models [ 8 ]. The type of exercise training to which mice are typically subjected to before/upon tumor inoculation also varies between studies (forced treadmill, forced swimming, voluntary wheel running). The duration of exercise in the trials typically consists of several weeks (~ 4 to 10 weeks), which can be translated to human “years.”

Exercise can have an impact on tumor development, growth or dissemination through several mechanisms. First, exercise might help to prevent cancer by reducing the circulating levels of several mediators, such as insulin growth factor-1 (IGF-1) [ 9 – 14 ], a mitogen that triggers cell proliferation [ 15 ]. Exercise can also reduce the levels of hyperphosphorylated retinoblastoma protein (Rb) in a chemically induced rat model of mammary carcinogenesis [ 16 , 17 ], increase ß-catenin phosphorylation in colon polyps [ 18 , 19 ], and reduce the levels of micro-RNA 21 [ 20 ].

Exercise can upregulate tumor suppressors, such as the tumor suppressor programmed cell death protein 4 in a murine model of estrogen receptor-positive breast cancer (BC) [ 21 ]. In addition, exercise-induced catecholamines might reduce BC development through activation of the Hippo tumor suppressor pathway [ 22 ] and exercise-induced increased p53 activation, leading to tumor prevention, as shown in mouse models of skin [ 13 , 23 ] and lung [ 24 ] cancer.

Exercise training can stimulate apoptosis, as shown in xenograft models of lung adenocarcinoma [ 24 ] and human pancreatic and prostate cancers [ 25 , 26 ] and in murine models of skin tumorigenesis [ 12 ] and mammary carcinoma [ 4 , 16 , 27 ]. Exercise also exerts proapoptotic effects on cultured prostate cancer cells [ 28 ], estrogen receptor-positive BC cells [ 29 , 30 ] and lymph node metastases of prostate tumor cells [ 25 ]. Exercise additionally reduces the levels of the antiapoptotic protein B cell lymphoma 2 [ 16 , 31 ] and stimulates the proapoptotic proteins Bax and Bak [ 4 , 16 , 24 ] and the protein kinase AMPK [ 32 , 33 ].

Hypoxia and poor blood supply promote an aggressive cancer phenotype and contribute to ineffective systemic therapy [ 34 ]. In this respect, exercise may promote a shift toward a more “normalized” tumor microenvironment by improving intratumoral perfusion/vascularization, at least in orthotopic murine models of human BC [ 4 , 35 ] and prostate cancer [ 36 – 38 ] and in xenografts of different tumors (melanoma, pancreas) [ 39 ].

Exercise might also attenuate the development of metastases. Mouse exercise training can decrease catenin while increasing E-cadherin inside tumors [ 19 , 40 ]. Importantly, cadherins act as glue between epithelial cells, and their loss can favor malignancy by allowing the disaggregation of cells, which can then invade locally or metastasize [ 40 ]. Moderate-intensity mouse swimming can suppress liver cancer metastases via boosting the activity of dopamine receptor 2 [ 40 ]. Exercise may also modulate blood–brain barrier integrity by maintaining the expression levels of occludin or claudin-5 proteins [ 41 ], thereby preventing metastatic progression to the brain [ 42 ]. On the other hand, inflammatory cells within the tumor microenvironment supply bioactive molecules that sustain cancer hallmarks [ 43 – 45 ]. In this context, mouse exercise training decreases macrophage infiltration in allogeneic lymphoid tumors [ 46 ], Ehrlich tumor cells [ 47 ] and colon polyps [ 18 ].

One major potential “anticancer” effect of exercise lies in an enhancement of immune function [ 43 , 48 ]. At moderate intensities, exercise can stimulate the innate immune system, especially natural killer (NK) cells [ 49 , 50 ]. A 6-week mouse wheel running program had preventive effects against the development of several types of tumors (melanoma, liver and lung cancers), and the effect was mediated by improved NK cell infiltration into the tumors, which in turn was mediated by the enhanced tumor expression of ligands for several NK cell-activating receptors [ 51 ]. A previous study showed that exercise training increased the cytolytic capacity of resident peritoneal macrophages against mastocytoma cells [ 52 ]. Mouse exercise training could also polarize the immunological response toward an efficient “antitumor” macrophage profile 1, which is linked to the production of T-helper 1 cytokines [ 52 – 56 ]. Short-term (6-day) moderate exercise before the injection of melanoma cells into mice decreased their metastatic spread, which was partially mediated by increased antitumor macrophage cytotoxicity [ 57 ]. Preliminary data from mice [ 53 , 58 – 60 ] and cancer patients suggest that exercise training may help to reduce the immunosuppressive effects of T regulatory lymphocytes [ 61 ]. Finally, regular exercise can increase alveolar macrophage antitumor cytotoxicity in vitro, which would mediate a protective effect against mouse lung metastases [ 62 , 63 ].

Importantly, skeletal muscle, especially during contractions, releases molecules collectively known as “myokines” into the bloodstream, which act systemically to induce a myriad of health-promoting effects, such as decreased inflammation and reduced insulin resistance [ 64 ]. Some myokines might also induce direct anticancer effects (via the stimulation of apoptosis in tumor cells), such as oncostatin M in hormone-sensitive BC [ 30 ] or secreted protein acidic and rich in cysteine (SPARC, also known as osteonectin) in colon cancer [ 65 ]. The aforementioned exercise-induced infiltration of NK cells into tumors seems to be mediated by the release of interleukin 6 by muscle into the bloodstream [ 49 , 51 , 66 ].

Physical activity and cancer prevention

According to the World Health Organization (WHO), up to 31% of the adult population worldwide and 35% in Europe are physically inactive [ 67 ]. PA is difficult to measure for the following reasons: (1) there are at least four domains: occupational, household, transportation and leisure time; (2) PA questionnaires on past and current activity are subject to recall bias; and (3) objective methods (pedometers or accelerometers) can only be used in prospective studies for short time periods, and they may not always represent overall PA. Fortunately, smartphones and other devices now allow PA monitoring and will hopefully provide more accurate measures in the future.

Body mass is related to PA and cancer risk, acting as a confounder. However, the prevention of adiposity may mediate the relationship between PA and cancer, and controlling for adiposity could lead to underestimating the real effect of PA [ 68 ].

Of note, 1 metabolic equivalent (MET) is the rate of energy expenditure while resting or 3.5 ml O 2 /kg body weight/min on average. Moderate PA (e.g., brisk walking) usually requires an energy expenditure of 3–6 MET, whereas vigorous PA (e.g., jogging) requires an energy expenditure above 6 MET. The WHO recommends that adults engage in ≥ 150 min/week of moderate PA or ≥ 75 min/week of vigorous PA or a combination thereof. If a person does an ~ 3 MET activity (e.g., brisk walking on a level surface) for 1 h, he or she has done 3 MET-hours of PA. If this person does this same PA on every day of the week, he/she has done 21 (= 3 × 7) MET-hours/week. If a person does an ~ 8 MET activity (e.g., jogging) for 1 h on each day of the week, he/she has done 56 (= 8 × 7) MET-hours/week.

The World Cancer Research Fund and the American Institute for Cancer Research periodically publish the conclusions of a panel reviewing evidence linking food, nutrition and PA with cancer risk [ 69 ]. The evidence is classified as follows: (1) convincing: available results support a causal relationship; (2) probable: evidence supports a probable causal relationship; and (3) limited: results are not considered sufficient to rate the relationship as convincing or probable. In the last category, a distinction is made between limited-suggestive evidence when an effect is reported but there were methodological problems and limited-not conclusive evidence when there were insufficient data and/or the results were too heterogeneous. The panel concluded that regular, sustained PA protects against several types of cancer independent of body fat [ 69 ]. This evidence comes from high-income countries and is mainly based on leisure-time PA. The three tumors with the most solid results are colon, postmenopausal BC and endometrial.

Colorectal cancer

The evidence for colon cancer is judged as “convincing,” with an overall risk reduction of approximately 20% in the most physically active group compared with the less active group [ 70 ]. The effect is weaker or absent for rectal cancer. However, a pooled analysis of 12 prospective cohort studies with information on leisure-time PA at baseline compared the group at the 90th percentile of PA with the group under the 10th percentile and showed a reduced incidence of both colon (13% reduction) and rectal cancer (12%) after controlling for body mass index (BMI) [ 71 ]. Regarding the amount of PA required to obtain maximum benefit, a cohort of more than 40,000 men in the USA (The Health Professionals Follow-up Study) showed that aerobic PA seems to be more beneficial and that overall PA is more relevant than the intensity of PA [ 72 ]. Finally, while a benefit was observed in men meeting current guidelines (17% risk reduction), the maximum benefit (32% risk reduction) was observed for PA ≥ 30 metabolic equivalents (MET)-hours/week, which is equivalent to 10 h or more of walking/week [ 72 ]. A meta-analysis evaluating the dose–response shape of PA for different endpoints, including colon cancer, showed that major gains occurred at lower levels of activity (up to 50 MET-hours/week), while a decrease in risk was minimal at levels higher than 50–65 MET-hours/week [ 73 ].

Breast cancer

The evidence for postmenopausal BC is judged as “probable” [ 74 ]. Most studies show a protective effect with a 13% decreased risk in high versus low PA groups [ 74 ]. For recreational PA, a nonlinear dose–response was observed with a greater decrease in the risk for PA activity at > 20 MET-hours/week [ 74 ]. The pooling analysis with information on baseline leisure PA showed a reduction of 7% in the incidence of BC between the 90th and the 10th percentiles of PA [ 71 ]. Evidence for PA in premenopausal BC was rated as “limited-suggestive” for total PA and as “probable” for vigorous-intensity PA [ 74 ]. In Canada, a cohort study with 39,000 women reported a clear downward trend of BC incidence based on the number of MET-hours/week, which was mainly due to the risk reduction observed for premenopausal tumors [ 75 ]. Finally, a case–control study in Spain showed a reduced risk of 5% per 6 MET-hours/week [ 76 ]. The protection was particularly important for nulliparous women (12% risk reduction per 6 MET-hours/week) [ 76 ].

Endometrial cancer

The evidence for endometrial cancer was rated as “probable,” and the results showed a lower risk of endometrial cancer with higher levels of PA [ 77 ]. A meta-analysis reported a 20% risk reduction in high versus low PA groups [ 78 ]. This inverse association was only observed in overweight/obese women [ 78 ]. The pooled analysis of PA at baseline in 12 cohorts showed a risk reduction of 21% between the two extreme deciles of PA before taking BMI into account, while adjusting for BMI reduced the benefit to a nonsignificant risk reduction of 2% [ 71 ]. In the stratified analyses, PA was only associated with endometrial cancer in women with a BMI equal to or greater than 25 [ 71 ].

Lung cancer

A recent report classifies the evidence for lung cancer as “limited-suggestive” [ 69 ]. Leisure-time PA was considered in a systematic review, showing a clear inverse association with all histological lung cancer subtypes but only among former or current smokers [ 79 ]. The pooled analysis of cohort studies on leisure-time PA reported a 27% reduction in lung cancer incidence in the highest decile of PA compared with the lowest [ 71 ]. Again, the effect was only observed among smokers [ 71 ].

Liver cancer

The World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) report classifies the evidence for liver cancer as “limited-suggestive” [ 80 ]. In the joint analysis of liver cancer incidence in 12 cohorts according to recreational PA at baseline, the highest decile had a hazard ratio (HR) of 0.73 before taking BMI into account and decreased to a nonsignificant HR of 0.81 when BMI was included as a confounder [ 71 ].

Esophageal cancer

There is limited but suggestive evidence of a protective effect of PA against esophageal adenocarcinoma and squamous cell carcinomas [ 81 ]. A meta-analysis found a risk ratio (RR) of 0.79 for esophageal adenocarcinoma and a nonsignificant RR of 0.94 for esophageal squamous cell carcinoma [ 82 ]. The pooled analyses of 1,44 million individuals from 12 cohorts showed an approximately 40% risk reduction in esophageal adenocarcinomas and a 24% risk reduction in esophageal squamous tumors for participants in the 90th percentile of leisure-time PA at baseline compared with the lowest PA group [ 71 ].

Stomach cancer

The recent WCRF/AICR update still considers limited-not conclusive evidence available for stomach cancer [ 83 ]. A previous meta-analysis on gastric cancer estimated an RR of 0.82 for high versus low PA [ 82 ]. The pooled analysis of leisure-time PA at baseline in the 12 cohorts showed a 22% risk reduction for gastric cardia tumors when BMI was not taken into account, but stratification by BMI showed that the protective effect was only observed among overweight/obese people [ 71 ].

Prostate cancer

There is a limited-not conclusive evidence of a link between PA and prostate cancer [ 84 ]. A systematic review showed substantial heterogeneity among 85 studies: 22 reported a statistically significant risk reduction, 25 reported a nonsignificant risk reduction, 31 did not find any association, and eight found an adverse effect of PA [ 85 ]. A higher incidence of prostate cancer (4% increase) was observed among the 10% more physically active participants in the pooled analysis of 12 cohort studies compared with those with a lower decile of activity. The authors hypothesized that this result could be due to a higher probability of prostate cancer screening in physically active men [ 71 ].

Ovarian cancer

The evidence for ovarian cancer was considered limited-not conclusive [ 86 ]. While most case–control studies found significant risk reductions among very active women, most cohort studies failed to show a clear effect [ 87 ]. The pooling analysis of 1.44 million participants in 12 prospective cohorts in the USA and Europe did not find a protective effect of high leisure-time PA for this tumor [ 71 ]. The Nurses’ Health Study, a prospective cohort with updated information on leisure-time PA, revealed an increased risk for both low and high levels of premenopausal PA, while no association was observed in postmenopausal women [ 88 ].

Pancreatic cancer

The WCRF/AICR report considers limited-not conclusive evidence for pancreatic cancer [ 89 ]. A meta-analysis yielded a statistically significant RR of 0.89 for high versus low PA [ 90 ]. Stronger effects were observed in case–control studies and for younger populations [ 90 ]. The pooling analysis of 12 cohort studies showed a non-statistically significant reduction of 5% in the most active group at baseline, but this effect was no longer observed when BMI was considered [ 71 ]. The EPIC-Norfolk cohort communicated a decreased risk in the highest category of total PA among participants younger than 60 years independent of BMI, while no effect was observed in older people [ 91 ].

Kidney cancer

The WCRF/AICR panel considers limited-not conclusive evidence for kidney cancer [ 92 ]; however, a meta-analysis in 2013 estimated a 12% risk reduction in the high PA group that was stronger when combining only high-quality studies [ 93 ]. The pooled analysis of the 12 cohorts showed a risk reduction of 16% independent of BMI among the most active group [ 71 ].

Bladder cancer

The evidence for bladder cancer is judged as limited-not conclusive [ 94 ]. A meta-analysis showed an RR of 0.85 for high versus low PA [ 95 ]. Moreover, the joint analysis of 12 prospective cohorts found a significantly reduced risk of bladder tumors in participants for the highest decile of leisure-time PA at baseline (HR = 0.88) [ 71 ].

Other tumors

A systematic review and meta-analysis on PA and hematologic cancers showed a reduced risk for non-Hodgkin lymphoma and nonsignificant results for multiple myeloma and leukemias [ 96 ]. The pooled analysis of 12 cohorts found a protective effect of PA against myeloid leukemia, myeloma and head–neck carcinomas [ 71 ]. Interestingly, malignant melanomas were more frequent in participants at the highest decile of leisure-time PA, a finding attributed to greater sun exposure due to outdoor activity and an increased risk of sunburn [ 71 ].

Summary and future directions

PA clearly reduces the risk of colon, BC and endometrial cancer. Furthermore, recent epidemiological studies suggest a protective effect for most cancer sites.

There is no conclusive evidence regarding the amount of PA needed to significantly reduce cancer risk, although it is likely tumor dependent.

New devices that routinely collect information on PA may help to increase the accuracy of PA measures and reduce information bias.

Effect of physical activity on the prognosis of cancer

Several reviews and meta-analyses of observational studies have suggested the benefit of PA on cancer outcomes. Most of the studies included breast cancer (Tables 1 , 2 ) and colon cancer survivors (Table 3 ). A few studies have been conducted on patients with other types of neoplasms, such as prostate (Table 4 ), esophageal, lung and kidney cancer (Table 5 ). In these studies, PA is reported as lifetime PA in the latest years before or after diagnosis. The outcomes reported are usually overall survival, cancer-related survival, cancer recurrence and quality of life (QoL). Table 1 Meta-analysis of observational and interventional studies on the impact of exercise on breast cancer outcome References Population PA Outcome Results Lahart et al. [ 97 ] 123,574 BC survivors 1994–2014 Most studies observational Pre-diagnosis All-cause mortality HR 0.82 (95% CI 0.75–0.96) BC mortality HR 0.73 (95% CI 0.54–0.98) BC events HR 0.72 (95% CI 0.56–0.91) After diagnosis All-cause mortality HR 0.52 (95% CI 0.43–0.64) BC mortality HR 0.59 (95% CI 0.45–0.78) BC events HR 0.79 (95% CI 0.63–0.98) Lahart et al. [ 98 ] 5761 BC survivors from 63 randomized trials PA intervention After diagnosis All-cause mortality No data BC recurrence No data HRQoL, emotional function, perceived physical function, anxiety, and cardiorespiratory fitness Small to moderate improvement BC, breast cancer; HRQoL, health-related quality of life; PA, physical activity Table 2 Summary of prospective observational studies on physical activity and prognosis in breast cancer patients Study/references Population LTPA Outcome Results Holmes et al. [ 99 ] Nurses’ Health Study 2987 Nurses with stage I-III BC, 1984–1998 After diagnosis ≥ 9 MET-h/week BC-specific mortality HR 0.50 (95% CI 0.34–0.74) Irwin et al. [ 100 ] HEAL Study 933 Women with BC 1995–1998 Pre-diagnosis ≥ 9 MET-h/week Overall survival HR 0.69 (95% CI 0.45–1.06) After diagnosis ≥ 9 MET-h/week Overall survival HR 0.33 (95% CI 0.15–0.73) Bao et al. [ 101 ] Shanghai BCSS 518 Women with TNBC After diagnosis ≥ 7.6 MET-h/week or ≥ 2.5 MET-h/week BC-specific mortality HR 0.58 (95% CI 0.39–0.86) BC recurrence HR 0.67 (95% CI 0.46–0.96) Schmidt et al. [ 102 ] Germany 3393 Women with early BC 50–74 year Pre-diagnosis ≥ 42 MET-h/week All-cause mortality HR 0.66 (95% CI 0.47–0.92) BC mortality HR 0.80 (95% CI 0.53–1.21) Cancer recurrence HR 0.65 (95% CI 0.44–0.97) Holick et al. [ 103 ] Florida-Boston 4482 Invasive BC 1998–2001 After diagnosis ≥ 21 MET-h/week BC mortality HR 0.51 (95% CI 0.29–0.89) All-cause mortality HR 0.44 (95% CI 0.32–0.60) Ammitzboll et al. [ 104 ] Danish Diet, Cancer and Health Cohort 959 BC survivors After diagnosis ≥ 8 MET-h/week All-cause mortality HR 0.67 (95% CI 0.47–0.99) Friedenreich et al. [ 105 ] Canadian 1233 BC survivors 1995–1997 Pre-diagnosis 46.9 MET-h/w BC mortality HR 0.56 (95% CI 0.38–0.82) BC recurrence HR 0.66 (95% CI 0.48–0.91) Sternfeld et al. [ 106 ] LACE Study Multivariable 1970 BC survivors PA 6 months prior to diagnosis BC mortality No association confirmed BC recurrence No association confirmed All-cause mortality HR 0.66 (95% CI 0.42–1.03) Irwin et al. [ 107 ] Women’s Health Initiative 4643 BC (in situ + invasive) Prior to diagnosis ≥ 9 MET-h/week All-cause mortality HR 0.61 (95% CI 0.44–0.87) After diagnosis ≥ 9 MET-h/week BC mortality HR 0.61 (95% CI 0.43–0.99) All-cause mortality HR 0.54 (95% CI 0.38–0.79) Bertram et al. [ 108 ] WHEL Study 2361 Women with stage I-III BC Baseline active All-cause mortality HR 0.47 (95% CI 0.26–0.84) BC events No effect Adherence to activity guidelines after 1 year post-diagnosis All-cause mortality HR 0.65 (95% CI 0.47–0.91) BC events No effect Bradshaw et al. [ 109 ] Long Island BC Study 1033 BC (in situ + invasive) 1995–1996 After diagnosis ≥ 9 MET-h/week All-cause mortality HR 0.33 (95% CI 0.22–0.48) BC mortality HR 0.27 (95% CI 0.15–0.46) BC, breast cancer; LTPA, leisure-time physical activity; MET-h/week, metabolic equivalent task hours per week; TNBC: triple-negative breast cancer BC events: BC progression, new primary BC, recurrence of BC Table 3 Summary of observational studies on physical activity and prognosis in colorectal cancer patients Study Population LTPA Outcome Results Walter et al. [ 110 ] 3121 CRC patients Latest LTPA ≥ 56 MET-h/week Overall mortality CRC mortality HR 0.75 (95% CI 0.61–0.91) HR 0.81 (95% CI 0.64–1.02) Arem et al. [ 111 ] AARP Diet and Health Study 3797 CRC patients 1759 CRC patients Pre-diagnosis LTPA > 7 MET-h/week Post-diagnosis LTPA > 7 MET-h/week Overall mortality Overall mortality HR 0.80 (95% CI 0.68–0.95) HR 0.69 (95% CI 0.49–0.98) Meyerhardt et al. [ 112 ] CALGB 89803 832 Patients with stage III CRC Post-diagnosis LTPA > 18 MET-h/week Disease-free survival HR 0.51 (95% CI 0.26–0.97) van Blarigan et al. [ 113 ] CALGB 89803 992 Patients with stage III colon cancer Post-diagnosis LTPA ≥ 8.75 MET-h/week Overall survival HR 0.64 (95% CI 0.45–0.92) Meyerhardt et al. [ 112 ] Nurses’ Health Study 57 Women with stage I-III CRC Post-diagnosis LTPA > 18 MET-h/week CRC mortality Overall mortality HR 0.39 (95% CI 0.18–0.82) HR 0.43 (95% CI 0.25–0.74) Campbell et al. [ 114 ] 2293 Patients with stage I-III CRC Pre-diagnosis LTPA ≥ 8.75 MET-h/week Post-diagnosis LTPA ≥ 8.75 MET-h/week All-cause mortality All-cause mortality RR 0.72 (95% CI 0.58–0.89) RR 0.58 (95% CI 0.47–0.71) CRC, colorectal cancer; LTPA, leisure-time physical activity; MET-h/week, metabolic equivalent task hours per week Table 4 Summary of observational studies on physical activity and prognosis in prostate cancer patients Study Population LTPA Outcome Results Richman et al. [ 115 ] N = 1455 Non-metastatic PC Walk briskly ≥ 3 h/week Rate of progression HR 0.43 (95% CI 0.21–0.91) Friedenreich et al. [ 116 ] N = 830 Stage II–IV PC 1997–2000 Post-diagnosis total activity > 119 MET-hours/week All-cause mortality HR 0.58 (95% CI 0.42–0.79) Pre- and post-diagnosis activity PC mortality HR 0.56 (95% CI 0.35–0.90) > 18 MET-hours/week All-cause mortality HR 0.66 (95% CI 0.49–0.88) Kenfield et al. [ 117 ] Health Professional Follow-up Study N = 2705 Non-metastatic PC 1990–2008 Post-diagnosis walking ≥ 90 min per week All-cause mortality HR 0.54 (95% CI 0.41–0.71) Post-diagnosis walking ≥ 3 h per week or vigorous activity All-cause mortality HR 0.51 (95% CI 0.36–0.72) LTPA, leisure-time physical activity; MET-h/week, metabolic equivalent task hours per week; PC, prostate cancer Table 5 Prospective observational studies on physical activity and prognosis in other cancers Study Population LTPA Outcome Results Liss et al. [ 118 ] Texas and San Diego 222,163 Kidney cancer survivors 1998–2004 Any PA Kidney cancer-specific mortality HR 0.50 (95% CI 0.27–0.93) Sloan et al. [ 119 ] Rochester, US 1466 Lung cancer survivors 1997–2009 Physically active Recurrence rate Overall survival 81% versus 82% ( P = 0.62) 8.4 year versus 4.4 year ( P < 0.0001) Wang et al. [ 120 ] Chinese 303 Early esophageal cancer survivors After surgery > 9 MET-h/week All-cause mortality Risk of recurrence HR 0.67 (95% CI 0.48–0.92) HR 0.31 (95% CI 0.22–0.43) HR, hazard ratio; LTPA, leisure-time physical activity; MET, metabolic equivalent; PA, physical activity

Epidemiologic and observational studies show a decrease in the risk of cancer recurrence and all-cause mortality in patients who practice regular PA [ 121 – 123 ]. A systematic review of studies published through June 2013 concluded that PA performed before or after cancer diagnosis is associated with a reduced mortality risk among BC and colorectal cancer survivors [ 124 ]. Mortality in adult survivors of childhood cancer was inferior in those patients who practiced vigorous exercise after diagnosis in a large multicentric observational study [ 125 ]. In 2015, Lahart et al. [ 97 ] published a meta-analysis of 22 studies analyzing the impact of PA on BC outcomes. A literature search was performed using PubMed, EMBASE and CENTRAL databases from 1995 to October 2014. In 40% of the observational studies, the risk of relapse and death in BC survivors decreased in most physically active women. Most studies included an analysis of leisure-time PA and only a few of interventional PA programs. The majority of the studies did not perform a multivariable analysis to exclude the effect of known confounding factors, and less than half included clinical prognostic factors, such as stage, nodal status, age or type of treatment. These studies found a positive impact on all-cause and BC mortality in patients who practiced moderate or intense lifetime PA before the diagnosis of BC and in recent years before diagnosis. However, the authors recommend interpreting these results with caution due to the large heterogeneity of the studies. A post-diagnosis activity of at least 10 MET-hours/week was associated with a decrease in all-cause, and BC mortality and was not influenced by the heterogeneity; however, not all the studies could corroborate a decrease in recurrence risk. The “After Breast Cancer Pooling Project” included more than 13,000 women from four prospective cohorts of BC survivors in the USA and Shanghai and analyzed the association between PA at 18–48 months after diagnosis and risk of all-cause and BC-specific mortality and BC recurrence [ 126 ]. BC mortality was reduced in patients who achieved 18.7 or more MET-hours/week, and no association was found between PA and BC recurrence [ 126 ]. A comprehensive review of sixty-three interventional studies on women after BC adjuvant therapy concluded that PA interventions might have certain beneficial effects on QoL, cardiorespiratory fitness and psychological and social functions, but conclusions about BC recurrence, BC mortality and all-cause mortality could not be made [ 98 ].

Several prospective observational studies and meta-analyses in patients with colorectal cancer have suggested the benefit of PA before and after diagnosis in terms of improvements on all-cause and cancer-specific mortality after controlling for other confounding factors, such as BMI, sex, number of positive lymph nodes, age, baseline performance status (PS), adjuvant chemotherapy regimen or recurrence-free survival period [ 110 , 111 , 127 , 128 ]. Similarly, three observational prospective studies in prostate cancer found a strong inverse relationship between exercise and the risk of cancer progression regardless of other known prognostic factors [ 115 – 117 ]. A Chinese study in patients who underwent esophagectomy for esophageal cancer supported the benefit of PA (> 9 MET-hours/week) on recurrence risk and all-cause mortality [ 120 ]. Data from a prospective observational study in kidney cancer survivors investigating PA and diet changes suggested a decrease in the recurrence rate in patients who did any PA compared with those that were totally inactive [ 118 ]. The only study in lung cancer survivors showed better overall survival in patients who met > 9 MET-hours/week, but no difference in the recurrence rate was observed [ 119 ].

In conclusion, the real impact of PA on the risk of relapse and cancer mortality is not well-defined. PA may contribute to reduced cancer-related mortality and all-cause mortality in cancer survivors by modifying fat accumulation and improving cardiovascular and skeletal muscle function [ 129 ]. Numerous prospective observational studies consistently showed the benefit of PA on cancer outcomes; however, most of these studies were based on measures from self-reported questionnaires, including heterogeneous populations, and only a few performed a multivariable analysis to exclude the contribution of other confounding factors. Interventional studies with reliable and objective measures of PA in homogeneous populations are needed to confirm the data from observational studies and to evaluate the real effect of exercise on cancer prognosis.

Exercise-oncology: a pragmatic point of view for clinicians

Exercise-oncology is a new field of cancer care with the goal of the appropriate and rationale introduction of exercise programs into the overall management of cancer patients to take advantage of the numerous benefits associated with PA. Several major comprehensive cancer centers have created exercise-oncology units to implement these programs in a timely and organized manner. A collaborative work among rehab specialists, physiotherapists and exercise physiologists, as well as oncologists and radio-oncology specialists, is developed in these units.

Exercise has demonstrated numerous benefits on the QoL of patients with cancer throughout the history of the disease, ameliorating the negative impact of cancer on physical and psychological health and having a positive impact on patient survival [ 130 – 133 ].

Despite these benefits, many questions about PA/exercise in cancer patients remain, as it is particularly challenging to elucidate how much exercise is needed to achieve patient improvements and how the exercise should be recommended and monitored by clinicians.

General PA/exercise recommendations for cancer patients

In 2010, the first exercise guidelines were published by a roundtable of the American College of Sports Medicine (ACSM) based on general WHO PA guidelines to the general population. These guidelines consist of a minimum exercise recommendation: 150 min of moderate-intensity exercise in 3–5 days combining 2 days of resistance exercise and 3 days of aerobic exercise or 70 min of high-intensity exercise combining 1 day of resistance exercise and 2 days of aerobic exercise [ 133 ].

Exercise in the cancer treatment continuum

First, it is important to highlight that exercise is feasible, effective and safe in patients with cancer throughout the course of the disease. However, there are specific recommendations for the different moments of the disease and its therapies.

Presurgical exercise

It has been shown that presurgical high-intensity interval training in cancer patients is feasible and effective in improving cardiorespiratory fitness, which is typically measured as peak oxygen uptake (VO 2peak ); this training makes sense when patients need to achieve a specific VO 2peak to undergo surgery, as noted for patients with lung cancer [ 134 ]. The intervention was based on high-intensity aerobic exercise (cycling) from 50 to 100% of VO 2peak for 30 min, 5 days per week.

In another study in patients with BC, a presurgical intervention consisting of 180 min of moderate aerobic exercise and 40 min of strength training per week was associated with physiological changes and alterations in gene expression in tumor tissue (notably, downregulation of pathways related to cell cycle, RNA transport and DNA replication) [ 135 ].

Exercise during chemotherapy

Several studies using PA concomitantly with neoadjuvant and adjuvant chemotherapy have been performed with different approaches, demonstrating safety, effectiveness and fitness improvements [ 136 ].

Exercise programs concomitant with neoadjuvant chemotherapy are usually focused on improving the VO 2peak level or maintaining it at the baseline range after cancer treatment. Interventions are based on at least 3 days per week with different durations (from 4 to 12 weeks) in 30- to 60-min session with variable intensities, which range from 55 to 60% of VO 2peak at the start to 70–100% of VO 2peak at the end [ 137 ].

Exercise interventions concomitant with adjuvant therapy must take into account a safe starting time to be sure that surgical wounds are completely scarred. Different reviews have shown that exercise improves fitness capacity [ 138 ] and might reduce some cancer-related side effects, such as fatigue [ 136 ]. However, interventions in these studies were heterogeneous and did not often describe the intensity or type of exercise used. A recent meta-analysis suggested that a workload of 600 MET (intensity-minutes) was associated with a clinically significant improvement in fitness capacity, suggesting that a 10-week program of 90 min/week of supervised training at 70% of VO 2peak may be sufficient [ 139 – 141 ]. Another meta-analysis found that cancer survivors who completed 15 MET-h/week presented a 27% lower risk of cancer mortality with respect to controls, and this effect was greater in patients who were sedentary at pre-diagnosis (35% lower risk) [ 142 ].

Despite the aggressiveness of cancer therapies, medium to high-intensity exercise and different types of exercise interventions are well-tolerated by most patients. Both previous reviews mentioned above focused on exercise intervention during neoadjuvant and adjuvant treatments, including high-intensity intervention [ 137 , 143 ].

In addition, resistance training has been shown to be safe and effective in preventing lean body mass loss and reducing body fat mass during neoadjuvant and adjuvant treatments [ 144 ].

Exercise in cancer survivors

It is well-known that cancer survivors obtain an improvement in QoL, body composition and physical fitness with exercise [ 130 , 131 , 144 – 146 ]. Again, the challenge in this population is to determine how much exercise is needed to achieve the maximum benefits. Related to exercise intensity, Gil-Rey et al. [ 147 ] showed that cancer survivors have an important reduction in their fitness capacity after cancer therapy and therefore suggest a reduction in exercise intensity at the beginning of training (i.e., 41–64% of VO 2max ). However, high-intensity training is feasible, safe and effective for cancer patients, and a shorter time of training is likely sufficient to obtain benefits, which should be taken into account in the implementation of exercise strategies [ 148 ].

More research is needed to determine the dose–response relationship between exercise and physical improvements given that some data from past clinical studies have suggested that an exercise intensity higher than that included in the general WHO recommendations might be needed to improve patients’ health status [ 147 ].

Exercise in patients with advanced and metastatic disease

Previous studies and reviews have shown that exercise is a safe and effective tool to improve fitness and functional capacity, strength, QoL and fatigue. Fitness and functional capacity were assessed by the VO 2peak and 6-min walking tests, showing significantly better results compared with the control group. In these studies, the aerobic exercise intensity ranged from 55 to 75% of VO 2peak [ 15 , 16 , 19 , 29 ]. Muscle strength was assessed with the one-repetition maximum (1RM) or estimated 1RM test (lower and upper limbs), and exercise intensity in these studies ranged from 40 to 80% of 1RM. Program durations ranged from 5 to 12 weeks [ 22 , 25 ]. With respect to body composition, significant changes were observed in lean mass, but no changes in fat mass, body mass or BMI were observed in previous studies. The low intensity of the exercise intervention (from 55 to 70% of VO 2peak ) might be a reason for these inconsistent results [ 15 , 16 , 33 ].

Exercise supervision

Although the benefits of exercise are well-established, the exercise dose–response and the best type of exercise in terms of duration and intensity remain unclear, making it difficult to establish how to provide specific recommendations to each individual patient and how to supervise the patient’s exercise by clinicians. With these caveats in mind, it might be wise to differentiate between patients who clearly need specialist counseling (as those under active treatment or metastatic patients, and all patients with side effects who limit them physically) and patients who do not (survival with limited side effects) (Fig. 1 ). An exercise-oncology specialist is an exercise professional with a previous background that includes a general qualification in exercise and health with specific knowledge in oncology items. Related to the oncology items, general knowledge about cancer biology, biomarkers and treatments and their side effects should be used to adapt to and individualize exercise to patients’ needs. Fig. 1 Distinguishing between patients who need specialist counseling and those who do not. Adaptation to the triage model for population-based screening of cancer survivors for weight management and physical activity interventions. Modified from National Academies of Sciences, Engineering, and Medicine 2018 [ 149 ]. Set. = setting; Tr. = training of professional; LS. = level of supervision. Specialist refers to clinicians, physical therapists, occupational therapists, dieticians, and clinical exercise physiologists

Challenges for patients: general supervision

For those patients who do not present the need for specialist counseling, the control of patients by informed clinicians could be sufficient to achieve reasonable results. In this respect, there are some specific guidelines that could be followed by patients and supervised by a nonspecialist with the help of different tests, devices or scales. For example, following WHO/ACSM guidelines or achieving more than 10,000 steps per day [ 150 ] are reasonable goals for cancer survivors (Table 6 ). Table 6 General challenges for patients without specialist counseling needs based on existing guidelines Recommendation Challenge Intensity WHO/ACSM guidelines 150 min per week 30 min/3 times “aerobic” exercise 30 min/2 times strength exercises Moderate 75 min per week 25 min/2 times aerobic exercise 25 min/1 time strength exercises High intensity Survival recommendations [ 99 , 107 , 147 , 151 ] 9 MET corresponding to 180 min of walking 5 km/h Review psychological benefits [ 152 ] 12 MET; 90–120 min Moderate intensity Minimum step recommendations [ 150 ] < 5000 steps/day “Sedentary lifestyle index” 5000–7499 steps/day It is typical of daily activity excluding sports/exercise and might be considered “low active” 7500–9999 “Somewhat active” ≥ 10,000 steps/day “Active” Individuals who take > 12,500 steps/day “Highly active” MET, metabolic equivalent

New technologies are improving methods to supervise the quality and quantity of exercise [ 153 ]. While behavioral interventions using text messages (with or without educational material and internet support) have produced limited effects on exercise adherence, mobile applications have been shown to be an effective and useful tool for both patients and providers to establish a healthy lifestyle. To achieve significant changes, it has been observed that these apps should include self-monitoring merged with other motivational techniques (goal setting, feedback on performance, review of goals, prompts, planning or barrier identifications, among others), allowing better supervision and control for patients and trainers [ 153 ].

Challenges for clinicians: learning exercise techniques

At present, exercise provides empowerment among health care providers, presenting a new challenge for them. One of the most important issues to address is who might prescribe and control exercise. It is possible that multidisciplinary committees, including oncologists, rehab departments and exercise physiologists, should be created to provide patients with the best counseling and training physicians to help individuals not requiring special help (Fig. 2 ). Fig. 2 Specialists and activities that should be developed by each specialist to achieve an adequate exercise intervention for oncologic patients while taking into account training principles adapted to exercise-oncology

However, while this scenario seems far away, other achievable proposals are feasible. The education of clinicians taking care of cancer patients and survivors about exercise techniques and control is a crucial point. Education and training should ideally start during university studies, although few institutions worldwide provide exercise theory and training to their future professionals. This education would have an impact not only in cancer patients but also on many other common pathologies such as cardiovascular, metabolic, joint and other diseases [ 154 ]. In accordance, patients’ associations playing a crucial role at present in providing exercise training and assistance until exercise will be included in the usual care.

Future lines of research

Despite the increasing number of studies addressing the benefits of exercise for cancer patients and survivors in the last 5 years, further research remains essential to clarify many unanswered questions. The establishment of new, more concrete guidelines for exercise in cancer patients is necessary not only for the exercise-oncology specialist but also for oncologists and other clinicians who take care of cancer patients.

There is an urgent need to further clarify the biological mechanism that makes exercise an effective method of intervention to decrease cancer incidence and mortality and to improve overall health in cancer patients. Studies of the modification of biological biomarkers before and after exercise are crucial for understanding the underlying mechanisms through which exercise can exert its influence on cancer biology. Several preclinical studies (discussed above) and clinical studies of small sample sizes have provided preliminary evidence on the relevance of the immune system, cytokines and insulin-related pathways [ 155 ]; however, because the evidence is preliminary, larger and statistically powerful studies are required.

In addition, new studies aimed at identifying the optimal intensity and duration of PA are needed. The characteristics of cancer survivors differ from those of the healthy population to whom the recommendations of the different health organizations are directed.

The best method of introducing exercise into the lifestyle of patients is also a matter to be addressed. The most effective behavioral interventions to achieve long-term changes in a patient’s lifestyle must be defined, bearing in mind that cancer diagnosis and treatment are “learning moments” in which patients are willing to change their daily activities to improve their health. The feasibility of using new technologies, such as mobile health applications and wrist and watch bands, as well as interventions based on social networks should be investigated to favor adherence and motivation to these programs of adapted PA.

In addition, future research on intervention in metastatic cancer stages should be performed due to the lack of knowledge in this area and the potential interest in improving the tolerance and effectiveness of treatments and the QoL of patients, many of whom can live today for many years after relapse due to the effective and sustained disease palliation that can be achieved with modern systemic treatments.

Conclusions

Regular PA is associated with major benefits to human health, including a reduced risk of some cancers.

The mechanisms through which exercise exerts its antitumor activity are still poorly understood but might be related to a direct effect on tumor cells (inhibition of tumor cell proliferation, induction of apoptosis, upregulation of tumor suppressor genes, anti-inflammatory effects) or to an enhancement of immune function.

There is convincing evidence that regular PA reduces the risk of colorectal cancer, while the reduction in postmenopausal BC and endometrial cancer risk is judged as probable. The effect of PA on the risk of other tumors is less evident but still possible.

Several epidemiological studies have suggested an association of regular PA with reduced cancer-related and all-cause mortality in some tumor types, particularly BC and colorectal cancer. The minimum amount of PA needed to achieve such a benefit is still unknown, although the US recommendations suggest that a minimum 10 MET-hours/week (equivalent to ≥ 150 min of moderate-intensity PA) is needed.

Exercise-oncology is a field of cancer care in which the goal is the introduction of exercise programs into the overall management of cancer patients. The first exercise guidelines for cancer patients were published in 2010 by the ACSM. These guidelines, which are mainly based on general WHO guidelines to the general population, consider that regular PA in cancer patients is safe and exerts positive effects in patients at multiple levels, particularly QoL. Exercise programs in cancer patients are feasible along the course of the disease, including the presurgical period, during adjuvant antitumor medical treatment (including chemotherapy) and in cancer survivors; a summary of these recommendations is shown in Table 7 . However, the experience with regular exercise in metastatic cancer patients is limited. Table 7 Exercise duration and intensity recommendation to cancer patients [ 147 , 156 ] Cancer treatment moment Type of exercise Description Intensity Duration (start with…) Examples Pre-surgery without other treatment Endurance High-intensity interval training 60–90% of VO 2peak [ 157 , 158 ] 20–35 min Walking Running Spinning Strength Global strength exercises Exercises with patient’s own body weight 0–40% of 1RM 2 sets of 10 repetitions Global strength circuits Stretching All body Passive or active stretches 30 s/exercise Yoga Stretching classes Surgery/mammary reconstructions Endurance Light intensity, avoid pain Depending on patient’ mobility [ 143 ] 20–40 min Walking biking Avoid swimming Strength Rehabilitation recommendations Rehabilitation recommendations Rehabilitation recommendations Upper-limb surgery: light arm mobility and postural exercises Abdominal surgery: hypopressive abdominal exercises, and postural exercises—including isometric exercises Stretching Rehabilitation recommendations Rehabilitation recommendations Rehabilitation recommendations Passive stretching without pain, focusing on affected area, when specialist allows it Under chemo/radiotherapy Endurance Adapted intervention to patient needs From 41 to 64% (moderate) to 80–90% of VO 2peak (high intensity, if the patient was previously active) 3 days per week/20–35 min Walking Dance Bike Spinning Running Avoid swimming Strength Global strength to prevent sarcopenia or cachexia From light movements to 40–60% of 1RM at first [ 159 ]. Depending on the patient’s comorbidities [ 143 ] 2 days per week, 2 sets of 10 repetitions Yoga Pilates Elastic bands Global strength circuits Machines Stretching Stretch gently all body. Special care with radiation areas. Avoid pain Passive stretches 30 s/exercise Yoga Stretching classes Under hormone therapy Endurance Moderate to high intensity depending on the patient’s previous situation. Rest for 48 h after high-intensity training From 41–64% (moderate) to 80–90% of VO 2peak (high intensity) if the patient was previously active 3 days per week/30–40 min Walking Dance Bike Spinning Running Swimming Strength Moderate to high intensity depending on the patient’s situation. Rest for 48 h after high-intensity training From light movements to 40–60% of 1RM [ 159 ] at first. Depending on the patient’s comorbidities [ 143 ] 2 days per week, 2 sets of 10 repetitions Yoga Pilates Elastic bands Global strength circuits Machines Stretch All body Passive or active stretches 30 s/exercise Yoga Stretching classes Survivors Endurance Moderate to high intensity depending on previous patients’ situation From 41 to 64% (moderate) to 80–100% of VO 2peak (intense) if the patient was initially active 3 days per week/30–40 min Walking Dance Bike Spinning Running Swimming Strength Moderate to high intensity depending on the patient’s previous situation. Special care for patients with functional limitations. Avoid pain. From light movements to 40–60% of 1RM [ 159 ] at first. Depending on the patient comorbidities [ 143 ] 2 days per week, 2 sets of 10 repetitions Yoga Pilates Elastic bands Global strength circuits Machines Stretch All body Passive or active stretches 30 s/exercise Yoga Stretching classes RM, repetition maximum; VO 2peak , peak oxygen uptake

The introduction of exercise programs into the global management of cancer patients remains a challenge due to conceptual and logistic issues. The most effective behavioral interventions to achieve long-term changes in a patient’s lifestyle must be defined. New technologies, such as mobile health applications and wrist and watch bands (the so-called “mHealth”), can be of great help to monitor the compliance to these programs. The optimal intensity and duration of PA should be defined with more precision in future studies. Regarding logistics, the intervention of both exercise-oncology specialists and trained clinicians is probably necessary at different time points to provide the best care. Several major comprehensive cancer centers have created exercise-oncology units to implement these programs in a timely and organized manner, and these models could serve as a reference for other institutions.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

M. Pollán and S. Casla-Barrio have equally contributed to this work.

Acknowledgements

We would like to thank to Fernando Rico-Villademoros, MD (COCIENTE S.L., Madrid, Spain) for his editorial assistance; his participation was funded by the Spanish Society of Medical Oncology (SEOM).

Author’s contribution

All authors were involved in the conception of this work, drafting and/or revising the manuscript, and approved the final version.

Funding

This positioning statement was funded by the Spanish Society of Medical Oncology (SEOM).

Compliance with ethical standards

Conflict of interest

MP declares that she have no conflict of interest; SC declares that she have no conflict of interest; JA received institutional research grants from Merck Serono and Novartis; CE received speaker’s honoraria from AstraZeneca, Roche, Novartis and Pfizer; MAS-P received consulting/advisory fees from AstraZeneca, Pfizer and Amgen, and speakers’ honoraria from Amgen, Roche and Pfizer; AL declares that he have no conflict of interest; MM has received research grants from Roche and Novartis, consulting/advisory fees from AstraZeneca, Amgen, Taiho Oncology, Roche/Genentech, Novartis, PharmaMar, Eli Lilly, PUMA Taiho Oncology and Pfizer, and speakers’ honoraria from AstraZeneca, Amgen, Roche/Genentech, Novartis and Pfizer.

Ethical approval

The manuscript does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent/ethical approval is not required for this type of project.

References

1. World Health Organization Physical activity 2018 Geneva WHO

2. National Cancer Institute. Cancer survivors and physical activity. 2018. https://progressreport.cancer.gov/after/physical_activity . Accessed 5 June 2019.

3. Figueira A Cortinhas A Soares J Leitão J Ferreira R Duarte J Efficacy of exercise on breast cancer outcomes: a systematic review and meta-analysis of preclinical data Int J Sports Med 2018 39 327 342 29564842 10.1055/s-0044-101149

4. Betof AS Lascola CD Weitzel D Landon C Scarbrough PM Devi GR Palmer G Jones LW Dewhirst MW Modulation of murine breast tumor vascularity, hypoxia, and chemotherapeutic response by exercise J Natl Cancer Inst 2015 107 djv040 25780062 10.1093/jnci/djv040 PMC4822524

5. Jones LW Eves N Courneya K Chiu B Baracos V Hanson J Johnson L Mackey J Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts Clin Cancer Res 2005 11 6695 6698 16166449 10.1158/1078-0432.CCR-05-0844

6. Jones LW Fels DR West M Allen JD Broadwater G Barry WT Wilke LG Masko E Douglas PS Dash RC Povsic TJ Peppercorn J Marcom PK Blackwell KL Kimmick G Turkington TG Dewhirst MW Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy Cancer Prev Res 2013 6 925 937 10.1158/1940-6207.CAPR-12-0416 PMC3800005 23842792

7. Sturgeon K Schadler K Muthukumaran G Ding D Bajulaiye A Thomas NJ Ferrari V Ryeom S Libonati JR Concomitant low-dose doxorubicin treatment and exercise Am J Physiol Regul Integr Comp Physiol 2014 307 R685 R692 25009215 10.1152/ajpregu.00082.2014 PMC4166763

8. Ruiz-Casado A Martín-Ruiz A Pérez LM Provencio M Fiuza-Luces C Lucia A Exercise and the hallmarks of cancer Trends Cancer 2017 3 423 441 28718417 10.1016/j.trecan.2017.04.007

9. Colbert LH Mai V Tooze J Perkins S Berrigan D Hursting S Negative energy balance induced by voluntary wheel running inhibits polyp development in APCMin mice Carcinogenesis 2006 27 2103 2107 16699175 10.1093/carcin/bgl056

10. Leung P-S Aronson WJ Ngo TH Golding LA Barnard RJ Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro J Appl Physiol 2004 96 450 454 14715676 10.1152/japplphysiol.00871.2003

11. Ouyang P Jiang Y Doan HM Xie L Vasquez D Welti R Su X Lu N Herndon B Yang SS Jeannotte R Wang W Weight loss via exercise with controlled dietary intake may affect phospholipid profile for cancer prevention in murine skin tissues Cancer Prev Res 2010 3 466 477 10.1158/1940-6207.CAPR-09-0021 PMC3081581 20233900

12. Xie L Jiang Y Ouyang P Chen J Doan H Herndon B Sylvester JE Zhang K Molteni A Reichle M Zhang R Haub MD Baybutt RC Wang W Effects of dietary calorie restriction or exercise on the PI3K and ras signaling pathways in the skin of mice J Biol Chem 2007 282 28025 28035 17646168 10.1074/jbc.M604857200

13. Yu M King B Ewert E Su X Mardiyati N Zhao Z Wang W Exercise activates p53 and negatively regulates IGF-1 pathway in epidermis within a skin cancer model PLoS ONE 2016 11 e0160939 27509024 10.1371/journal.pone.0160939 PMC4979999

14. Zhu Z Jiang W Zacher JH Neil ES McGinley JN Thompson HJ Effects of energy restriction and wheel running on mammary carcinogenesis and host systemic factors in a rat model Cancer Prev Res 2012 5 414 422 10.1158/1940-6207.CAPR-11-0454 PMC3294132 22246620

15. Kalaany NY Sabatini DM Tumours with PI3K activation are resistant to dietary restriction Nature 2009 458 725 731 19279572 10.1038/nature07782 PMC2692085

16. Jiang W Zhu Z Thompson HJ Effects of physical activity and restricted energy intake on chemically induced mammary carcinogenesis Cancer Prev Res 2009 2 338 344 10.1158/1940-6207.CAPR-08-0169 PMC4342186 19336733

17. Zhu Z Jiang W Sells JL Neil ES McGinley JN Thompson HJ Effect of nonmotorized wheel running on mammary carcinogenesis: circulating biomarkers, cellular processes, and molecular mechanisms in rats Cancer Epidemiol Biomark Prev 2008 17 1920 1929 10.1158/1055-9965.EPI-08-0175 PMC2667869 18708381

18. Baltgalvis KA Berger FG Peña MMO Davis JM Carson JA Effect of exercise on biological pathways in ApcMin/+ mouse intestinal polyps J Appl Physiol 2008 104 1137 1143 18239078 10.1152/japplphysiol.00955.2007

19. Ju J Nolan B Cheh M Bose M Lin Y Wagner GC Yang CS Voluntary exercise inhibits intestinal tumorigenesis in Apc Min/+ mice and azoxymethane/dextran sulfate sodium-treated mice BMC Cancer 2008 8 316 18976499 10.1186/1471-2407-8-316 PMC2635383

20. Horak M Zlamal F Iliev R Kucera J Cacek J Svobodova L Hlavonova Z Kalina T Slaby O Bienertova-Vasku J Exercise-induced circulating microRNA changes in athletes in various training scenarios PLoS ONE 2018 13 e0191060 29338015 10.1371/journal.pone.0191060 PMC5770042

21. Khori V Amani Shalamzari S Isanejad A Alizadeh Ali M Alizadeh S Khodayari S Khodayari H Shahbazi S Zahedi A Sohanaki H Khaniki M Mahdian R Saffari M Fayad R Effects of exercise training together with tamoxifen in reducing mammary tumor burden in mice: possible underlying pathway of miR-21 Eur J Pharmacol 2015 765 179 187 26300395 10.1016/j.ejphar.2015.08.031

22. Dethlefsen C Hansen LS Lillelund C Andersen C Gehl J Christensen JF Pedersen BK Hojman P Exercise-induced catecholamines activate the hippo tumor suppressor pathway to reduce risks of breast cancer development Cancer Res 2017 77 4894 4904 28887324 10.1158/0008-5472.CAN-16-3125

23. Lu YP Lou YR Nolan B Peng QY Xie JG Wagner GC Conney AH Stimulatory effect of voluntary exercise or fat removal (partial lipectomy) on apoptosis in the skin of UVB light-irradiated mice Proc Natl Acad Sci USA 2006 103 16301 16306 17060638 10.1073/pnas.0607789103 PMC1637577

24. Higgins KA Park D Lee GY Curran WJ Deng X Exercise-induced lung cancer regression: mechanistic findings from a mouse model Cancer 2014 120 3302 3310 24989479 10.1002/cncr.28878 PMC4682566

25. Zheng X Cui XX Huang MT Liu Y Shih WJ Lin Y Lu YP Wagner GC Conney AH Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice Oncol Rep 2008 19 1583 1588 18497969 PMC2825748

26. Zheng X Cui X-X Huang M-T Liu Y Wagner GC Lin Y Shih WJ Lee M-J Yang CS Conney AH Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise Nutr Cancer 2012 64 1029 1037 23061906 10.1080/01635581.2012.716899

27. Zhu Z Jiang W McGinley JN Thompson HJ Energetics and mammary carcinogenesis: effects of moderate-intensity running and energy intake on cellular processes and molecular mechanisms in rats J Appl Physiol 2009 106 911 918 19095749 10.1152/japplphysiol.91201.2008 PMC2660253

28. Soliman S Aronson WJ Barnard RJ Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention Evid Based Complement Altern Med 2011 2011 529053 10.1093/ecam/nep031 PMC3135793 19376839

29. Barnard RJ Hong Gonzalez J Liva ME Ngo TH Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro Nutr Cancer 2006 55 28 34 16965238 10.1207/s15327914nc5501_4

30. Hojman P Dethlefsen C Brandt C Hansen J Pedersen L Pedersen BK Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth Am J Physiol Endocrinol Metabol 2011 301 E504 E510 10.1152/ajpendo.00520.2010 21653222

31. He C Bassik MC Moresi V Sun K Wei Y Zou Z An Z Loh J Fisher J Sun Q Korsmeyer S Packer M May HI Hill JA Virgin HW Gilpin C Xiao G Bassel-Duby R Scherer PE Levine B Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis Nature 2012 481 511 515 22258505 10.1038/nature10758 PMC3518436

32. Piguet A-C Saran U Simillion C Keller I Terracciano L Reeves HL Dufour J-F Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis J Hepatol 2015 62 1296 1303 25623824 10.1016/j.jhep.2015.01.017

33. Sanchis-Gomar F Sestrins: novel antioxidant and AMPK-modulating functions regulated by exercise? J Cell Physiol 2013 228 1647 1650 23359071 10.1002/jcp.24338

34. Shannon AM Bouchier-Hayes DJ Condron CM Toomey D Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies Cancer Treat Rev 2003 29 297 307 12927570 10.1016/s0305-7372(03)00003-3

35. Jones LW Viglianti BL Tashjian JA Kothadia SM Keir ST Freedland SJ Potter MQ Jung Moon E Schroeder T Herndon JE Dewhirst MW Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer J Appl Physiol 2010 108 343 348 19959769 10.1152/japplphysiol.00424.2009 PMC2822670

36. Jones LW Antonelli J Masko EM Broadwater G Lascola CD Fels D Dewhirst MW Dyck JRB Nagendran J Flores CT Betof AS Nelson ER Pollak M Dash RC Young ME Freedland SJ Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer J Appl Physiol 2012 113 263 272 22604887 10.1152/japplphysiol.01575.2011 PMC3404704

37. McCullough DJ Nguyen LMD Siemann DW Behnke BJ Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model J Appl Physiol 2013 115 1846 1854 24177690 10.1152/japplphysiol.00949.2013 PMC3882937

38. McCullough DJ Stabley JN Siemann DW Behnke BJ Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise J Natl Cancer Inst 2014 106 dju036 24627275 10.1093/jnci/dju036 PMC3982888

39. Schadler KL Thomas NJ Galie PA Bhang DH Roby KC Addai P Till JE Sturgeon K Zaslavsky A Chen CS Ryeom S Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy Oncotarget 2016 7 65429 65440 27589843 10.18632/oncotarget.11748 PMC5323166

40. Zhang QB Zhang BH Zhang KZ Meng XT Jia QA Zhang QB Bu Y Zhu XD Ma DN Ye BG Zhang N Ren ZG Sun HC Tang ZY Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system Oncogene 2016 35 4122 4131 26686088 10.1038/onc.2015.484

41. Wolff G Davidson SJ Wrobel JK Toborek M Exercise maintains blood–brain barrier integrity during early stages of brain metastasis formation Biochem Biophys Res Commun 2015 463 811 817 26056010 10.1016/j.bbrc.2015.04.153 PMC4506929

42. Jia W Lu R Martin TA Jiang WG The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review) Mol Med Rep 2014 9 779 785 24366267 10.3892/mmr.2013.1875

43. Hanahan D Weinberg Robert A Hallmarks of cancer: the next generation Cell 2011 144 646 674 21376230 10.1016/j.cell.2011.02.013

44. Koelwyn GJ Quail DF Zhang X White RM Jones LW Exercise-dependent regulation of the tumour microenvironment Nat Rev Cancer 2017 17 620 632 28943640 10.1038/nrc.2017.78

45. Wiggins JM Opoku-Acheampong AB Baumfalk DR Siemann DW Behnke BJ Exercise and the tumor microenvironment Exerc Sport Sci Rev 2018 46 56 64 29166299 10.1249/JES.0000000000000137

46. Zielinski MR Muenchow M Wallig MA Horn PL Woods JA Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization J Appl Physiol 2004 96 2249 2256 15020578 10.1152/japplphysiol.01210.2003 PMC3645346

47. Almeida PWM Gomes-Filho A Ferreira AJ Rodrigues CEM Dias-Peixoto MF Russo RC Teixeira MM Cassali GD Ferreira E Santos IC Garcia AMC Silami-Garcia E Wisløff U Pussieldi GA Swim training suppresses tumor growth in mice J Appl Physiol 2009 107 261 265 19478194 10.1152/japplphysiol.00249.2009

48. Walsh NP Gleeson M Shephard RJ Gleeson M Woods JA Bishop NC Fleshner M Green C Pedersen BK Hoffman-Goetz L Rogers CJ Northoff H Abbasi A Simon P Position statement. Part one: immune function and exercise Exerc Immunol Rev 2011 17 6 63 21446352

49. Idorn M Hojman P Exercise-dependent regulation of NK cells in cancer protection Trends Mol Med 2016 22 565 577 27262760 10.1016/j.molmed.2016.05.007

50. Kruijsen-Jaarsma M Revesz D Bierings MB Buffart LM Takken T Effects of exercise on immune function in patients with cancer: a systematic review Exerc Immunol Rev 2013 19 120 143 23977724

51. Pedersen L Idorn M Olofsson Gitte H Lauenborg B Nookaew I Hansen Rasmus H Johannesen Helle H Becker Jürgen C Pedersen Katrine S Dethlefsen C Nielsen J Gehl J Pedersen Bente K Thor Straten P Hojman P Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution Cell Metabol 2016 23 554 562 10.1016/j.cmet.2016.01.011 26895752

52. Lu Q Ceddia MA Price EA Ye SM Woods JA Chronic exercise increases macrophage-mediated tumor cytolysis in young and old mice Am J Physiol Regul Integr Comp Physiol 1999 276 R482 R489 10.1152/ajpregu.1999.276.2.R482 9950928

53. Abdalla DR Murta EFC Michelin MA The influence of physical activity on the profile of immune response cells and cytokine synthesis in mice with experimental breast tumors induced by 7,12-dimethylbenzanthracene Eur J Cancer Prev 2013 22 251 258 22976388 10.1097/CEJ.0b013e3283592cbb

54. Abdalla DR Aleixo AAR Murta EFC Michelin MA Innate immune response adaptation in mice subjected to administration of DMBA and physical activity Oncol Lett 2014 7 886 890 24520305 10.3892/ol.2013.1774 PMC3919953

55. Kizaki T Takemasa T Sakurai T Izawa T Hanawa T Kamiya S Haga S Imaizumi K Ohno H Adaptation of macrophages to exercise training improves innate immunity Biochem Biophys Res Commun 2008 372 152 156 18474227 10.1016/j.bbrc.2008.05.005

56. Koelwyn GJ Wennerberg E Demaria S Jones LW Exercise in regulation of inflammation-immune axis function in cancer initiation and progression Oncology (Williston Park) 2015 29 908–20 22 PMC4909049 26676894

57. Murphy EA Davis JM Brown AS Carmichael MD Mayer EP Ghaffar A Effects of moderate exercise and oat β-glucan on lung tumor metastases and macrophage antitumor cytotoxicity J Appl Physiol 2004 97 955 959 15145923 10.1152/japplphysiol.00252.2004

58. Goh J Tsai J Bammler TK Farin FM Endicott E Ladiges WC Exercise training in transgenic mice is associated with attenuation of early breast cancer growth in a dose-dependent manner PLoS ONE 2013 8 e80123 24312199 10.1371/journal.pone.0080123 PMC3842299

59. McClellan JL Steiner JL Day SD Enos RT Davis MJ Singh UP Murphy EA Exercise effects on polyp burden and immune markers in the ApcMin/+ mouse model of intestinal tumorigenesis Int J Oncol 2014 45 861 868 24859893 10.3892/ijo.2014.2457 PMC4432723

60. Wang J Song H Tang X Yang Y Vieira VJ Niu Y Ma Y Effect of exercise training intensity on murine T-regulatory cells and vaccination response Scand J Med Sci Sports 2012 22 643 652 21410542 10.1111/j.1600-0838.2010.01288.x

61. Hampras SS Nesline M Wallace PK Odunsi K Furlani N Davis W Moysich KB Predictors of immunosuppressive regulatory T lymphocytes in healthy women J Cancer Epidemiol 2012 2012 191090 22969801 10.1155/2012/191090 PMC3433139

62. Davis JM Kohut ML Jackson DA Colbert LH Mayer EP Ghaffar A Exercise effects on lung tumor metastases and in vitro alveolar macrophage antitumor cytotoxicity Am J Physiol Regul Integr Comp Physiol 1998 274 R1454 R1459 10.1152/ajpregu.1998.274.5.R1454 9612414

63. Frellstedt L Waldschmidt I Gosset P Desmet C Pirottin D Bureau F Farnir F Franck T Dupuis-Tricaud M-C Lekeux P Art T Training modifies innate immune responses in blood monocytes and in pulmonary alveolar macrophages Am J Respir Cell Mol Biol 2014 51 135 142 24502337 10.1165/rcmb.2013-0341OC

64. Fiuza-Luces C Garatachea N Berger NA Lucia A Exercise is the real polypill Physiology 2013 28 330 358 23997192 10.1152/physiol.00019.2013

65. Aoi W Naito Y Takagi T Tanimura Y Takanami Y Kawai Y Sakuma K Hang LP Mizushima K Hirai Y Koyama R Wada S Higashi A Kokura S Ichikawa H Yoshikawa T A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise Gut 2012 62 882 889 22851666 10.1136/gutjnl-2011-300776

66. Benatti FB Pedersen BK Exercise as an anti-inflammatory therapy for rheumatic diseases—myokine regulation Nat Rev Rheumatol 2015 11 86 97 25422002 10.1038/nrrheum.2014.193

67. World Health Organization Assessing national capacity for the prevention and control of noncommunicable diseases 2012 Geneva WHO

68. Leitzmann M Powers H Anderson AS Scoccianti C Berrino F Boutron-Ruault M-C Cecchini M Espina C Key TJ Norat T Wiseman M Romieu I European code against cancer 4th edition: physical activity and cancer Cancer Epidemiol 2015 39 S46 S55 26187327 10.1016/j.canep.2015.03.009

69. World Cancer Research Fund/American Institute for Cancer Research Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007 Washington, DC AICR 10.1017/S002966510800712X 18452640

70. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and colorectal cancer. 2017. http://wcrf.org/colorectal-cancer-2017 . Accessed 5 June 2019.

71. Moore SC Lee IM Weiderpass E Campbell PT Sampson JN Kitahara CM Keadle SK Arem H Berrington de Gonzalez A Hartge P Adami H-O Blair CK Borch KB Boyd E Check DP Fournier A Freedman ND Gunter M Johannson M Khaw K-T Linet MS Orsini N Park Y Riboli E Robien K Schairer C Sesso H Spriggs M Van Dusen R Wolk A Matthews CE Patel AV Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults JAMA Intern Med 2016 176 816 825 27183032 10.1001/jamainternmed.2016.1548 PMC5812009

72. Keum N Bao Y Smith-Warner SA Orav J Wu K Fuchs CS Giovannucci EL Association of physical activity by type and intensity with digestive system cancer risk JAMA Oncol 2016 2 1146 1153 27196375 10.1001/jamaoncol.2016.0740 PMC5846204

73. Kyu HH Bachman VF Alexander LT Mumford JE Afshin A Estep K Veerman JL Delwiche K Iannarone ML Moyer ML Cercy K Vos T Murray CJL Forouzanfar MH Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013 BMJ 2016 354 i3857 27510511 10.1136/bmj.i3857 PMC4979358

74. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of breast cancer. 2010. http://www.aicr.org/continuous-update-project/reports/Breast-Cancer-2010-Report.pdf . Accessed 10 April 2017.

75. Catsburg C Kirsh VA Soskolne CL Kreiger N Bruce E Ho T Leatherdale ST Rohan TE Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort Breast Cancer Res Treat 2014 145 545 552 24781974 10.1007/s10549-014-2973-z

76. Lope V Martín M Castelló A Casla S Ruiz A Baena-Cañada JM Casas AM Calvo L Bermejo B Muñoz M Ramos M de Juan-Ferré A Jara C Antón A Jimeno MÁ Lluch A Antolín S García-Sáenz JÁ Estévez P Arriola-Arellano E Gavilá J Pérez-Gómez B Carrasco E Pollán M Physical activity and breast cancer risk by pathological subtype Gynecol Oncol 2017 144 577 585 28057355 10.1016/j.ygyno.2016.12.014

77. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of endometrial cancer. 2013. http://www.wcrf.org/sites/default/files/Endometrial-Cancer-2013-Report . Accessed 5 June 2019.

78. Schmid D Behrens G Keimling M Jochem C Ricci C Leitzmann M A systematic review and meta-analysis of physical activity and endometrial cancer risk Eur J Epidemiol 2015 30 397 412 25800123 10.1007/s10654-015-0017-6

79. Brenner DR Yannitsos DH Farris MS Johansson M Friedenreich CM Leisure-time physical activity and lung cancer risk: a systematic review and meta-analysis Lung Cancer 2016 95 17 27 27040847 10.1016/j.lungcan.2016.01.021

80. World Cancer Research Fund International/American Institute for Cancer Research. Continuous update project report: diet, nutrition, physical activity and liver cancer. 2015. http://www.wcrf.org/sites/default/files/Liver-Cancer-2015-Report.pdf . Accessed 5 June 2019.

81. World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and oesophageal cancer. 2016. http://www.wcrf.org/sites/default/files/Oesophageal-Cancer-2016-Report.pdf . Accessed 5 June 2019.

82. Behrens G Jochem C Keimling M Ricci C Schmid D Leitzmann MF The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis Eur J Epidemiol 2014 29 151 170 24705782 10.1007/s10654-014-9895-2

83. World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and stomach cancer. 2016. http://www.wcrf.org/sites/default/files/Stomach-Cancer-2016-Report.pdf . Accessed 5 June 2019.

84. World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity, and prostate cancer. 2014. http://www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf . Accessed 5 June 2019.

85. Shephard RJ Physical activity and prostate cancer: an updated review Sports Med 2017 47 1055 1073 27844337 10.1007/s40279-016-0648-0

86. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of ovarian cancer. 2014. http://www.dietancancerreport.org/cup/cupresources.php . Accessed 5 June 2019.

87. Cannioto RA Moysich KB Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription Gynecol Oncol 2015 137 559 573 25797080 10.1016/j.ygyno.2015.03.016 PMC4447575

88. Huang T Eliassen AH Hankinson SE Okereke OI Kubzansky LD Wang M Poole EM Chavarro JE Tworoger SS A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: impact by menopausal status Int J Cancer 2016 138 843 852 26335147 10.1002/ijc.29834 PMC4715531

89. World Cancer Research Fund/American Institute for Cancer Research. Continous Update Project Expert Report 2018. Food, nutrition, physical activity, and the prevention of pancreatic cancer. Available at http://dietandcancerreport.org . Accesed 4 June 2019.

90. Farris MS Mosli MH McFadden AA Friedenreich CM Brenner DR The association between leisure time physical activity and pancreatic cancer risk in adults: a systematic review and meta-analysis Cancer Epidemiol Biomark Prev 2015 24 1462 1473 10.1158/1055-9965.EPI-15-0301 26174790

91. Noor NM Banim PJR Luben RN Khaw K-T Hart AR Investigating physical activity in the etiology of pancreatic cancer Pancreas 2016 45 388 393 26390426 10.1097/MPA.0000000000000494 PMC4743065

92. World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and kidney cancer. 2015. www.wcrf/kidney-cancer-2015 . Accessed 5 June 2019.

93. Behrens G Leitzmann MF The association between physical activity and renal cancer: systematic review and meta-analysis Br J Cancer 2013 108 798 811 23412105 10.1038/bjc.2013.37 PMC3590672

94. World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and bladder cancer. 2015. http://www.wcrf.org/sites/default/files/Bladder-Cancer-2015-Report.pdf . Accessed 5 June 2019.

95. Keimling M Behrens G Schmid D Jochem C Leitzmann MF The association between physical activity and bladder cancer: systematic review and meta-analysis Br J Cancer 2014 110 1862 1870 24594995 10.1038/bjc.2014.77 PMC3974090

96. Jochem C Leitzmann MF Keimling M Schmid D Behrens G Physical activity in relation to risk of hematologic cancers: a systematic review and meta-analysis Cancer Epidemiol Biomark Prev 2014 23 833 846 10.1158/1055-9965.EPI-13-0699 24633143

97. Lahart IM Metsios GS Nevill AM Carmichael AR Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies Acta Oncol 2015 54 635 654 25752971 10.3109/0284186X.2014.998275

98. Lahart IM Metsios GS Nevill AM Carmichael AR Physical activity for women with breast cancer after adjuvant therapy Cochrane Database Syst Rev 2018 1 CD011292 29376559 10.1002/14651858.CD011292.pub2 PMC6491330

99. Holmes MD Chen WY Feskanich D Kroenke CH Colditz GA Physical activity and survival after breast cancer diagnosis JAMA 2005 293 2479 2486 15914748 10.1001/jama.293.20.2479

100. Irwin ML Smith AW McTiernan A Ballard-Barbash R Cronin K Gilliland FD Baumgartner RN Baumgartner KB Bernstein L Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study J Clin Oncol 2008 26 3958 3964 18711185 10.1200/JCO.2007.15.9822 PMC2654316

101. Bao P-P Zhao G-M Shu X-O Peng P Cai H Lu W Zheng Y Modifiable lifestyle factors and triple-negative breast cancer survival Epidemiology 2015 26 909 916 26360370 10.1097/EDE.0000000000000373 PMC4586952

102. Schmidt ME Chang-Claude J Vrieling A Seibold P Heinz J Obi N Flesch-Janys D Steindorf K Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer Int J Cancer 2013 133 1431 1440 23444048 10.1002/ijc.28130

103. Holick CN Newcomb PA Trentham-Dietz A Titus-Ernstoff L Bersch AJ Stampfer MJ Baron JA Egan KM Willett WC Physical activity and survival after diagnosis of invasive breast cancer Cancer Epidemiol Biomark Prev 2008 17 379 386 10.1158/1055-9965.EPI-07-0771 18250341

104. Ammitzbøll G Søgaard K Karlsen RV Tjønneland A Johansen C Frederiksen K Bidstrup P Physical activity and survival in breast cancer Eur J Cancer 2016 66 67 74 27529756 10.1016/j.ejca.2016.07.010

105. Friedenreich CM Gregory J Kopciuk KA Mackey JR Courneya KS Prospective cohort study of lifetime physical activity and breast cancer survival Int J Cancer 2009 124 1954 1962 19123472 10.1002/ijc.24155

106. Sternfeld B Weltzien E Quesenberry CP Castillo AL Kwan M Slattery ML Caan BJ Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study Cancer Epidemiol Biomark Prev 2009 18 87 95 10.1158/1055-9965.EPI-08-0595 PMC3507507 19124485

107. Irwin ML McTiernan A Manson JE Thomson CA Sternfeld B Stefanick ML Wactawski-Wende J Craft L Lane D Martin LW Chlebowski R Physical activity and survival in postmenopausal women with breast cancer: results from the women’s health initiative Cancer Prev Res 2011 4 522 529 10.1158/1940-6207.CAPR-10-0295 PMC3123895 21464032

108. Bertram LAC Stefanick ML Saquib N Natarajan L Patterson RE Bardwell W Flatt SW Newman VA Rock CL Thomson CA Pierce JP Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study Cancer Causes Control 2011 22 427 435 21184262 10.1007/s10552-010-9714-3 PMC3042101

109. Bradshaw PT Ibrahim JG Khankari N Cleveland RJ Abrahamson PE Stevens J Satia JA Teitelbaum SL Neugut AI Gammon MD Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study Breast Cancer Res Treat 2014 145 735 742 24789444 10.1007/s10549-014-2966-y PMC4358816

110. Walter V Jansen L Knebel P Chang-Claude J Hoffmeister M Brenner H Physical activity and survival of colorectal cancer patients: population-based study from Germany Int J Cancer 2017 140 1985 1997 28120416 10.1002/ijc.30619

111. Arem H Pfeiffer RM Engels EA Alfano CM Hollenbeck A Park Y Matthews CE Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health—AARP diet and health study J Clin Oncol 2015 33 180 188 25488967 10.1200/JCO.2014.58.1355 PMC4279238

112. Meyerhardt JA Giovannucci EL Holmes MD Chan AT Chan JA Colditz GA Fuchs CS Physical activity and survival after colorectal cancer diagnosis J Clin Oncol 2006 24 3527 3534 16822844 10.1200/JCO.2006.06.0855

113. van Blarigan EL Fuchs CS Niedzwiecki D Zhang S Saltz LB Mayer RJ Mowat RB Whittom R Hantel A Benson A Atienza D Messino M Kindler H Venook A Ogino S Giovannucci EL Ng K Meyerhardt JA Association of survival with adherence to the american cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis JAMA Oncol 2018 4 783 790 29710284 10.1001/jamaoncol.2018.0126 PMC6145685

114. Campbell PT Patel AV Newton CC Jacobs EJ Gapstur SM Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival J Clin Oncol 2013 31 876 885 23341510 10.1200/JCO.2012.45.9735

115. Richman EL Kenfield SA Stampfer MJ Paciorek A Carroll PR Chan JM Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor Cancer Res 2011 71 3889 3895 21610110 10.1158/0008-5472.CAN-10-3932 PMC3107352

116. Friedenreich CM Wang Q Neilson HK Kopciuk KA McGregor SE Courneya KS Physical activity and survival after prostate cancer Eur Urol 2016 70 576 585 26774959 10.1016/j.eururo.2015.12.032

117. Kenfield SA Stampfer MJ Giovannucci E Chan JM Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study J Clin Oncol 2011 29 726 732 21205749 10.1200/JCO.2010.31.5226 PMC3056656

118. Liss M Natarajan L Hasan A Noguchi JL White M Parsons JK Physical activity decreases kidney cancer mortality Curr Urol 2017 10 193 198 29234262 10.1159/000447180 PMC5704719

119. Sloan JA Cheville AL Liu H Novotny PJ Wampfler JA Garces YI Clark MM Yang P Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship Health Qual Outcomes 2016 14 66 10.1186/s12955-016-0461-3 PMC4850698 27129406

120. Wang L Wang C Wang J Huang X Cheng Y Longitudinal, observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy Sci Rep 2016 6 1572 1581 10.1038/srep38962 PMC5154179 27958342

121. Ballard-Barbash R Friedenreich CM Courneya KS Siddiqi SM McTiernan A Alfano CM Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review J Natl Cancer Inst 2012 104 815 840 22570317 10.1093/jnci/djs207 PMC3465697

122. Gunnell AS Joyce S Tomlin S Taaffe DR Cormie P Newton RU Joseph D Spry N Einarsdóttir K Galvão DA Physical activity and survival among long-term cancer survivor and non-cancer cohorts Front Public Health 2017 5 19 28261579 10.3389/fpubh.2017.00019 PMC5306330

123. Li T Wei S Shi Y Pang S Qin Q Yin J Deng Y Chen Q Wei S Nie S Liu L The dose–response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies Br J Sports Med 2016 50 339 345 26385207 10.1136/bjsports-2015-094927

124. Schmid D Leitzmann MF Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis Ann Oncol 2014 25 1293 1311 24644304 10.1093/annonc/mdu012

125. Scott JM Li N Liu Q Yasui Y Leisenring W Nathan PC Gibson T Armenian SH Nilsen TS Oeffinger KC Ness KK Adams SC Robison LL Armstrong GT Jones LW Association of exercise with mortality in adult survivors of childhood cancer JAMA Oncol 2018 4 1352 1358 29862412 10.1001/jamaoncol.2018.2254 PMC6181767

126. Beasley JM Kwan ML Chen WY Weltzien EK Kroenke CH Lu W Nechuta SJ Cadmus-Bertram L Patterson RE Sternfeld B Shu X-O Pierce JP Caan BJ Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project Breast Cancer Res Treat 2012 131 637 643 21935600 10.1007/s10549-011-1770-1 PMC3272362

127. Jeon J Sato K Niedzwiecki D Ye X Saltz LB Mayer RJ Mowat RB Whittom R Hantel A Benson A Wigler DS Atienza D Messino M Kindler H Venook A Fuchs CS Meyerhardt JA Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: findings from CALGB 89803/alliance Clin Colorectal Cancer 2013 12 233 238 24035029 10.1016/j.clcc.2013.06.005 PMC3818492

128. Meyerhardt JA Heseltine D Niedzwiecki D Hollis D Saltz LB Mayer RJ Thomas J Nelson H Whittom R Hantel A Schilsky RL Fuchs CS Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803 J Clin Oncol 2006 24 3535 3541 16822843 10.1200/JCO.2006.06.0863

129. Haykowsky MJ Scott JM Hudson K Denduluri N Lifestyle interventions to improve cardiorespiratory fitness and reduce breast cancer recurrence Am Soc Clin Oncol Educ Book 2017 37 57 64 28561685 10.1200/EDBK_175349

130. Casla S Hojman P Márquez-Rodas I López-Tarruella S Jerez Y Barakat R Martín M Running away from side effects: physical exercise as a complementary intervention for breast cancer patients Clin Transl Oncol 2015 17 180 196 24894838 10.1007/s12094-014-1184-8

131. Mishra SI Scherer RW Geigle PM Berlanstein DR Topaloglu O Gotay CC Snyder C Exercise interventions on health-related quality of life for cancer survivors Cochrane Database Syst Rev 2012 10.1002/14651858.cd007566.pub2 22895961 PMC7387117

132. Mishra SI Scherer RW Snyder C Geigle PM Berlanstein DR Topaloglu O Exercise interventions on health-related quality of life for people with cancer during active treatment Cochrane Database Syst Rev 2012 10.1002/14651858.cd008465.pub2 22895974 PMC7389071

133. Schmitz KH Courneya KS Matthews C Demark-Wahnefried W GalvÃO DA Pinto BM Irwin ML Wolin KY Segal RJ Lucia A Schneider CM Von Gruenigen VE Schwartz AL American college of sports medicine roundtable on exercise guidelines for cancer survivors Med Sci Sports Exerc 2010 42 1409 1426 20559064 10.1249/MSS.0b013e3181e0c112

134. Jones LW Eves ND Peddle CJ Courneya KS Haykowsky M Kumar V Winton TW Reiman T Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions Appl Physiol Nutr Metabol 2009 34 197 202 10.1139/H08-104 19370050

135. Ligibel JA, Irwin M, Dillon D, Barry W, Giobbie-Hurder A, Frank E, Winer EP, McTiernan A, Cornwell M, Pun M, Brown M, Jeselsohn R. Impact of pre-operative exercise on breast cancer gene expresision. In: Proceedings of the thirty-ninth annual CTRC–AACR San Antonio breast cancer symposium. San Antonio: American Association for Cancer Research; 2017. p. 77.

136. Furmaniak AC Menig M Markes MH Exercise for women receiving adjuvant therapy for breast cancer Cochrane Database Syst Rev 2016 9 CD005001 27650122 10.1002/14651858.CD005001.pub3 PMC6457768

137. Loughney L West MA Kemp GJ Grocott MPW Jack S Exercise intervention in people with cancer undergoing neoadjuvant cancer treatment and surgery: a systematic review Eur J Surg Oncol 2016 42 28 38 26506862 10.1016/j.ejso.2015.09.027

138. Loughney L West MA Kemp GJ Grocott MPW Jack S Exercise intervention in people with cancer undergoing adjuvant cancer treatment following surgery: a systematic review Eur J Surg Oncol 2015 41 1590 1602 26358569 10.1016/j.ejso.2015.08.153

139. Beaudry RI Liang Y Boyton ST Tucker WJ Brothers RM Daniel KM Rao R Haykowsky MJ Meta-analysis of exercise training on vascular endothelial function in cancer survivors Integr Cancer Ther 2018 17 192 199 29390904 10.1177/1534735418756193 PMC6041934

140. Nelson ME Rejeski WJ Blair SN Duncan PW Judge JO King AC Macera CA Castaneda-Sceppa C Physical activity and public health in older adults Med Sci Sports Exerc 2007 39 1435 1445 17762378 10.1249/mss.0b013e3180616aa2

141. Turner RR Steed L Quirk H Greasley RU Saxton JM Taylor SJC Rosario DJ Thaha MA Bourke L Interventions for promoting habitual exercise in people living with and beyond cancer Cochrane Database Syst Rev 2018 9 CD010192 30229557 10.1002/14651858.CD010192.pub3 PMC6513653

142. Jones LW Liu Q Armstrong GT Ness KK Yasui Y Devine K Tonorezos E Soares-Miranda L Sklar CA Douglas PS Robison LL Oeffinger KC Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study J Clin Oncol 2014 32 3643 3650 25311213 10.1200/JCO.2014.56.7511 PMC4220043

143. Sasso JP Eves ND Christensen JF Koelwyn GJ Scott J Jones LW A framework for prescription in exercise-oncology research J Cachexia Sarcopenia Muscle 2015 6 115 124 26136187 10.1002/jcsm.12042 PMC4458077

144. Padilha CS Marinello PC Galvão DA Newton RU Borges FH Frajacomo F Deminice R Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis J Cancer Surviv 2017 11 339 349 28054255 10.1007/s11764-016-0592-x

145. Jones LW Courneya KS Vallance JKH Ladha AB Mant MJ Belch AR Stewart DA Reiman T Association between exercise and quality of life in multiple myeloma cancer survivors Support Care Cancer 2004 12 780 788 15322968 10.1007/s00520-004-0668-4

146. Mills RC Breast cancer survivors, common markers of inflammation, and exercise: a narrative review Breast Cancer Basic Clin Res 2017 11 117822341774397 10.1177/1178223417743976 PMC5802700 29434469

147. Gil-Rey E Quevedo-Jerez K Maldonado-Martin S Herrero-Román F Exercise intensity guidelines for cancer survivors: a comparison with reference values Int J Sports Med 2014 35 e1 e9 25429545 10.1055/s-0034-1389972

148. Toohey K Pumpa K McKune A Cooke J Semple S High-intensity exercise interventions in cancer survivors: a systematic review exploring the impact on health outcomes J Cancer Res Clin Oncol 2018 144 1 12 29210001 10.1007/s00432-017-2552-x PMC11813318

149. National Academies of Sciences EM, Health and Medicine Division. Board on health care services, national cancer policy forum. Incorporating weight management and physical activity throughout the cancer care continuum. In: Proceedings of a workshop. Washington, DC: National Academies Press; 2018. 29206390

150. Tudor-Locke C Bassett DR How many steps/day are enough? Sports Med 2004 34 1 8 14715035 10.2165/00007256-200434010-00001

151. Chen X Lu W Zheng W Gu K Matthews CE Chen Z Zheng Y Shu XO Exercise after diagnosis of breast cancer in association with survival Cancer Prev Res 2011 4 1409 1418 10.1158/1940-6207.CAPR-10-0355 PMC3169008 21795422

152. Carayol M Bernard P Boiché J Riou F Mercier B Cousson-Gélie F Romain AJ Delpierre C Ninot G Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol 2013 24 291 300 23041586 10.1093/annonc/mds342

153. Valle C. Enhancing benefits of exercise for the survivor using emerging technology. In: ASCO Annual Meeting. Chicago; 201.

154. Joyner MJ Sanchis-Gomar F Lucia A Exercise medicine education should be expanded Br J Sports Med 2017 51 625 626 27797731 10.1136/bjsports-2016-096620

155. McDermott LA Murphy MH McNeilly AM Rankin JP Gracey JH Biological markers as an outcome measure of exercise in cancer rehabilitation: a systematic review J Cancer Res Ther 2018 14 267 277 29516906 10.4103/0973-1482.191036

156. Campbell KL Winters-Stone KM Wiskemann J May AM Schwartz AL Courneya KS Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable Med Sci Sports Exerc 2019 51 2375 2390 31626055 10.1249/MSS.0000000000002116 PMC8576825

157. Jones LW Peddle CJ Eves ND Haykowsky MJ Courneya KS Mackey JR Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions Cancer 2007 110 590 598 17582629 10.1002/cncr.22830

158. Jones LW Hornsby WE Goetzinger A Forbes LM Sherrard EL Quist M Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer Lung Cancer 2012 76 248 252 22112290 10.1016/j.lungcan.2011.10.009 PMC3615546

159. Travier N Velthuis MJ Steins Bisschop CN van den Buijs B Monninkhof EM Backx F Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial BMC Med 2015 13 121 26050790 10.1186/s12916-015-0362-z PMC4461906